Selected research
Industry Research
Azacitidine Drug Industry Research Report 2026
Market perspective
The global Azacitidine Drug market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
The North America market for Azacitidine Drug is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.
The Europe market for Azacitidine Drug is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.
Read the full market overview
The Asia Pacific market for Azacitidine Drug is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.
Leading global manufacturers of Azacitidine Drug include Accord Healthcare, Celgene, Dr. Reddy's Laboratories, EVER Pharma, Getwell Oncology, MBA Pharmaceuticals Pvt Ltd, Natco Pharma, Rizochem Pharmaceutical and Shilpa Medicare, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report quantifies the global Azacitidine Drug market in terms of revenue (US$ million) and, where applicable, sales volume (k units), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/k units) and concentration ratios (CR5/CR10).
The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.
Key Companies & Market Share Insights
This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Azacitidine Drug Market by Company
Accord Healthcare
Celgene
Dr. Reddy's Laboratories
EVER Pharma
Getwell Oncology
MBA Pharmaceuticals Pvt Ltd
Natco Pharma
Rizochem Pharmaceutical
Shilpa Medicare
Shubham Pharmaceutical
Taj Generics
Xpreza
Mylan
Azacitidine Drug Segment by Type
Vidaza®
Generic Vidaza®
Azacitidine Drug Segment by Application
Chronic myelomonocytic leukemia (CMMoL)
Refractory anemia (RA)
Refractory anemia with excess blasts (RAEB)
Others
Azacitidine Drug Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Azacitidine Drug market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Azacitidine Drug and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Azacitidine Drug.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Azacitidine Drug manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Azacitidine Drug by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Azacitidine Drug in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Vidaza®
- Generic Vidaza®
Applications
- Chronic myelomonocytic leukemia (CMMoL)
- Refractory anemia (RA)
- Refractory anemia with excess blasts (RAEB)
- Others
Companies covered
- Accord Healthcare
- Celgene
- Dr. Reddy's Laboratories
- EVER Pharma
- Getwell Oncology
- MBA Pharmaceuticals Pvt Ltd
- Natco Pharma
- Rizochem Pharmaceutical
- Shilpa Medicare
- Shubham Pharmaceutical
- Taj Generics
- Xpreza
- Mylan
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Global Market Growth Prospects
- 2.2.1 Global Azacitidine Drug Market Size (2021-2032)
- 2.2.2 Global Azacitidine Drug Sales (2021-2032)
- 2.2.3 Global Azacitidine Drug Market Average Price (2021-2032)
- 2.3 Azacitidine Drug by Type
- 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
- 2.3.2 Vidaza®
- 2.3.3 Generic Vidaza®
- 2.4 Azacitidine Drug by Application
- 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.4.2 Chronic myelomonocytic leukemia (CMMoL)
- 2.4.3 Refractory anemia (RA)
- 2.4.4 Refractory anemia with excess blasts (RAEB)
- 2.4.5 Others
3 Market Competitive Landscape by Manufacturers
- 3.1 Global Azacitidine Drug Market Competitive Situation by Manufacturers (2021 Versus 2025)
- 3.2 Global Azacitidine Drug Sales (k units) of Manufacturers (2021-2026)
- 3.3 Global Azacitidine Drug Revenue of Manufacturers (2021-2026)
- 3.4 Global Azacitidine Drug Average Price by Manufacturers (2021-2026)
- 3.5 Global Azacitidine Drug Industry Ranking, 2024 VS 2025 VS 2026
- 3.6 Global Manufacturers of Azacitidine Drug, Manufacturing Sites & Headquarters
- 3.7 Global Manufacturers of Azacitidine Drug, Product Type & Application
- 3.8 Global Manufacturers of Azacitidine Drug, Established Date
- 3.9 Global Azacitidine Drug Market CR5 and HHI
- 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
- 4.1 Accord Healthcare
- 4.1.1 Accord Healthcare Company Information
- 4.1.2 Accord Healthcare Business Overview
- 4.1.3 Accord Healthcare Azacitidine Drug Sales, Revenue and Gross Margin (2021-2026)
- 4.1.4 Accord Healthcare Azacitidine Drug Product Portfolio
- 4.1.5 Accord Healthcare Recent Developments
- 4.2 Celgene
- 4.2.1 Celgene Company Information
- 4.2.2 Celgene Business Overview
- 4.2.3 Celgene Azacitidine Drug Sales, Revenue and Gross Margin (2021-2026)
- 4.2.4 Celgene Azacitidine Drug Product Portfolio
- 4.2.5 Celgene Recent Developments
- 4.3 Dr. Reddy's Laboratories
- 4.3.1 Dr. Reddy's Laboratories Company Information
- 4.3.2 Dr. Reddy's Laboratories Business Overview
- 4.3.3 Dr. Reddy's Laboratories Azacitidine Drug Sales, Revenue and Gross Margin (2021-2026)
- 4.3.4 Dr. Reddy's Laboratories Azacitidine Drug Product Portfolio
- 4.3.5 Dr. Reddy's Laboratories Recent Developments
- 4.4 EVER Pharma
- 4.4.1 EVER Pharma Company Information
- 4.4.2 EVER Pharma Business Overview
- 4.4.3 EVER Pharma Azacitidine Drug Sales, Revenue and Gross Margin (2021-2026)
- 4.4.4 EVER Pharma Azacitidine Drug Product Portfolio
- 4.4.5 EVER Pharma Recent Developments
- 4.5 Getwell Oncology
- 4.5.1 Getwell Oncology Company Information
- 4.5.2 Getwell Oncology Business Overview
- 4.5.3 Getwell Oncology Azacitidine Drug Sales, Revenue and Gross Margin (2021-2026)
- 4.5.4 Getwell Oncology Azacitidine Drug Product Portfolio
- 4.5.5 Getwell Oncology Recent Developments
- 4.6 MBA Pharmaceuticals Pvt Ltd
- 4.6.1 MBA Pharmaceuticals Pvt Ltd Company Information
- 4.6.2 MBA Pharmaceuticals Pvt Ltd Business Overview
- 4.6.3 MBA Pharmaceuticals Pvt Ltd Azacitidine Drug Sales, Revenue and Gross Margin (2021-2026)
- 4.6.4 MBA Pharmaceuticals Pvt Ltd Azacitidine Drug Product Portfolio
- 4.6.5 MBA Pharmaceuticals Pvt Ltd Recent Developments
- 4.7 Natco Pharma
- 4.7.1 Natco Pharma Company Information
- 4.7.2 Natco Pharma Business Overview
- 4.7.3 Natco Pharma Azacitidine Drug Sales, Revenue and Gross Margin (2021-2026)
- 4.7.4 Natco Pharma Azacitidine Drug Product Portfolio
- 4.7.5 Natco Pharma Recent Developments
- 4.8 Rizochem Pharmaceutical
- 4.8.1 Rizochem Pharmaceutical Company Information
- 4.8.2 Rizochem Pharmaceutical Business Overview
- 4.8.3 Rizochem Pharmaceutical Azacitidine Drug Sales, Revenue and Gross Margin (2021-2026)
- 4.8.4 Rizochem Pharmaceutical Azacitidine Drug Product Portfolio
- 4.8.5 Rizochem Pharmaceutical Recent Developments
- 4.9 Shilpa Medicare
- 4.9.1 Shilpa Medicare Company Information
- 4.9.2 Shilpa Medicare Business Overview
- 4.9.3 Shilpa Medicare Azacitidine Drug Sales, Revenue and Gross Margin (2021-2026)
- 4.9.4 Shilpa Medicare Azacitidine Drug Product Portfolio
- 4.9.5 Shilpa Medicare Recent Developments
- 4.10 Shubham Pharmaceutical
- 4.10.1 Shubham Pharmaceutical Company Information
- 4.10.2 Shubham Pharmaceutical Business Overview
- 4.10.3 Shubham Pharmaceutical Azacitidine Drug Sales, Revenue and Gross Margin (2021-2026)
- 4.10.4 Shubham Pharmaceutical Azacitidine Drug Product Portfolio
- 4.10.5 Shubham Pharmaceutical Recent Developments
- 4.11 Taj Generics
- 4.11.1 Taj Generics Company Information
- 4.11.2 Taj Generics Business Overview
- 4.11.3 Taj Generics Azacitidine Drug Sales, Revenue and Gross Margin (2021-2026)
- 4.11.4 Taj Generics Azacitidine Drug Product Portfolio
- 4.11.5 Taj Generics Recent Developments
- 4.12 Xpreza
- 4.12.1 Xpreza Company Information
- 4.12.2 Xpreza Business Overview
- 4.12.3 Xpreza Azacitidine Drug Sales, Revenue and Gross Margin (2021-2026)
- 4.12.4 Xpreza Azacitidine Drug Product Portfolio
- 4.12.5 Xpreza Recent Developments
- 4.13 Mylan
- 4.13.1 Mylan Company Information
- 4.13.2 Mylan Business Overview
- 4.13.3 Mylan Azacitidine Drug Sales, Revenue and Gross Margin (2021-2026)
- 4.13.4 Mylan Azacitidine Drug Product Portfolio
- 4.13.5 Mylan Recent Developments
5 Global Azacitidine Drug Market Scenario by Region
- 5.1 Global Azacitidine Drug Market Size by Region: 2021 VS 2025 VS 2032
- 5.2 Global Azacitidine Drug Sales by Region: 2021-2032
- 5.2.1 Global Azacitidine Drug Sales by Region: 2021-2026
- 5.2.2 Global Azacitidine Drug Sales by Region: 2027-2032
- 5.3 Global Azacitidine Drug Revenue by Region: 2021-2032
- 5.3.1 Global Azacitidine Drug Revenue by Region: 2021-2026
- 5.3.2 Global Azacitidine Drug Revenue by Region: 2027-2032
- 5.4 North America Azacitidine Drug Market Facts & Figures by Country
- 5.4.1 North America Azacitidine Drug Market Size by Country: 2021 VS 2025 VS 2032
- 5.4.2 North America Azacitidine Drug Sales by Country (2021-2032)
- 5.4.3 North America Azacitidine Drug Revenue by Country (2021-2032)
- 5.4.4 United States
- 5.4.5 Canada
- 5.4.6 Mexico
- 5.5 Europe Azacitidine Drug Market Facts & Figures by Country
- 5.5.1 Europe Azacitidine Drug Market Size by Country: 2021 VS 2025 VS 2032
- 5.5.2 Europe Azacitidine Drug Sales by Country (2021-2032)
- 5.5.3 Europe Azacitidine Drug Revenue by Country (2021-2032)
- 5.5.4 Germany
- 5.5.5 France
- 5.5.6 U.K.
- 5.5.7 Italy
- 5.5.8 Russia
- 5.5.9 Spain
- 5.5.10 Netherlands
- 5.5.11 Switzerland
- 5.5.12 Sweden
- 5.5.13 Poland
- 5.6 Asia Pacific Azacitidine Drug Market Facts & Figures by Country
- 5.6.1 Asia Pacific Azacitidine Drug Market Size by Country: 2021 VS 2025 VS 2032
- 5.6.2 Asia Pacific Azacitidine Drug Sales by Country (2021-2032)
- 5.6.3 Asia Pacific Azacitidine Drug Revenue by Country (2021-2032)
- 5.6.4 China
- 5.6.5 Japan
- 5.6.6 South Korea
- 5.6.7 India
- 5.6.8 Australia
- 5.6.9 Taiwan
- 5.6.10 Southeast Asia
- 5.7 South America Azacitidine Drug Market Facts & Figures by Country
- 5.7.1 South America Azacitidine Drug Market Size by Country: 2021 VS 2025 VS 2032
- 5.7.2 South America Azacitidine Drug Sales by Country (2021-2032)
- 5.7.3 South America Azacitidine Drug Revenue by Country (2021-2032)
- 5.7.4 Brazil
- 5.7.5 Argentina
- 5.7.6 Chile
- 5.8 Middle East and Africa Azacitidine Drug Market Facts & Figures by Country
- 5.8.1 Middle East and Africa Azacitidine Drug Market Size by Country: 2021 VS 2025 VS 2032
- 5.8.2 Middle East and Africa Azacitidine Drug Sales by Country (2021-2032)
- 5.8.3 Middle East and Africa Azacitidine Drug Revenue by Country (2021-2032)
- 5.8.4 Egypt
- 5.8.5 South Africa
- 5.8.6 Israel
- 5.8.7 Türkiye
- 5.8.8 GCC Countries
6 Segment by Type
- 6.1 Global Azacitidine Drug Sales by Type (2021-2032)
- 6.1.1 Global Azacitidine Drug Sales by Type (2021-2032) & (k units)
- 6.1.2 Global Azacitidine Drug Sales Market Share by Type (2021-2032)
- 6.2 Global Azacitidine Drug Revenue by Type (2021-2032)
- 6.2.1 Global Azacitidine Drug Sales by Type (2021-2032) & (US$ Million)
- 6.2.2 Global Azacitidine Drug Revenue Market Share by Type (2021-2032)
- 6.3 Global Azacitidine Drug Price by Type (2021-2032)
7 Segment by Application
- 7.1 Global Azacitidine Drug Sales by Application (2021-2032)
- 7.1.1 Global Azacitidine Drug Sales by Application (2021-2032) & (k units)
- 7.1.2 Global Azacitidine Drug Sales Market Share by Application (2021-2032)
- 7.2 Global Azacitidine Drug Revenue by Application (2021-2032)
- 7.2.1 Global Azacitidine Drug Sales by Application (2021-2032) & (US$ Million)
- 7.2.2 Global Azacitidine Drug Revenue Market Share by Application (2021-2032)
- 7.3 Global Azacitidine Drug Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
- 8.1 Azacitidine Drug Value Chain Analysis
- 8.1.1 Azacitidine Drug Key Raw Materials
- 8.1.2 Raw Materials Key Suppliers
- 8.1.3 Azacitidine Drug Production Mode & Process
- 8.2 Azacitidine Drug Sales Channels Analysis
- 8.2.1 Direct Comparison with Distribution Share
- 8.2.2 Azacitidine Drug Distributors
- 8.2.3 Azacitidine Drug Customers
9 Global Azacitidine Drug Analyzing Market Dynamics
- 9.1 Azacitidine Drug Industry Trends
- 9.2 Azacitidine Drug Industry Drivers
- 9.3 Azacitidine Drug Industry Opportunities and Challenges
- 9.4 Azacitidine Drug Industry Restraints
10 Report Conclusion
11 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst